| NCT07019922 | A Clinical Trial of Elsunersen in Pediatric SCN2A-DEE to Assess Efficacy and Safety | RECRUITING | PHASE3 | 2025-08-13 | 2028-12 | 2026-06 |
| NCT07010471 | A Clinical Trial for Participants With DEE to Assess Efficacy, Safety, Tolerability, and PK of Relutrigine | RECRUITING | PHASE3 | 2025-07-09 | 2027-07 | 2026-07 |
| NCT06840925 | A Clinical Trial to Evaluate the Relative Bioavailability of PRAX-628 | NOT_YET_RECRUITING | PHASE1 | 2025-03-24 | 2025-06-30 | 2025-05-30 |
| NCT06908356 | An Open Label Trial to Evaluate the Efficacy and Safety of PRAX-628 in Adults With Focal Onset or Tonic-Clonic Seizures | RECRUITING | PHASE2 | 2025-01-10 | 2025-07 | 2025-07 |
| NCT06999902 | Double-blind, Randomized Trial of PRAX-628 in Adults With Focal Seizures to Evaluate Efficacy and Safety (POWER1) | RECRUITING | PHASE2, PHASE3 | 2024-12-11 | 2025-12-08 | 2025-11-24 |
| NCT06087276 | Essential 3 - Decentralized, Phase 3 Study Evaluating the Safety and Efficacy of Ulixacaltamide in Essential Tremor (ET) | ENROLLING_BY_INVITATION | PHASE3 | 2023-11-02 | 2026-12 | 2025-09 |
| NCT05818553 | A Clinical Trial of PRAX-562 in Subjects With Developmental and Epileptic Encephalopathies (DEE) | RECRUITING | PHASE2, PHASE3 | 2023-08-02 | 2027-03-01 | 2026-03-23 |
| NCT05737784 | A Clinical Trial of PRAX-222 in Pediatric Participants With Early Onset SCN2A Developmental and Epileptic Encephalopathy | RECRUITING | PHASE1, PHASE2 | 2023-04-13 | 2027-09 | 2025-08 |
| NCT05387642 | A Clinical Trial of PRAX-114 in Participants With Essential Tremor | WITHDRAWN | PHASE2 | 2022-04-05 | 2022-06-30 | 2022-06-30 |
| NCT05260541 | A Clinical Trial of PRAX-114 in Participants With Post-Traumatic Stress Disorder | TERMINATED | PHASE2 | 2022-01-25 | 2022-09-23 | 2022-08-01 |
| NCT05021991 | A Clinical Trial of 2 Doses of PRAX-944 in Participants With Essential Tremor | COMPLETED | PHASE2 | 2021-10-14 | 2024-02-29 | 2023-02-09 |
| NCT04969510 | A Clinical Trial of Adjunctive and Monotherapy PRAX-114 in Participants With Major Depressive Disorder | COMPLETED | PHASE2 | 2021-06-24 | 2022-08-02 | 2022-07-15 |
| NCT04832425 | A Clinical Trial of PRAX-114 in Participants With Major Depressive Disorder | COMPLETED | PHASE2, PHASE3 | 2021-03-30 | 2022-05-05 | 2022-05-05 |
| NCT05021978 | A Clinical Trial of PRAX-944 in Participants With Essential Tremor | COMPLETED | PHASE2 | 2020-03-03 | 2022-03-24 | 2022-03-24 |